海口地区2家医院2007～2009年降血脂药利用分析  

Analysis on the Utilization of Blood Lipid-lowering Drugs in 2 Hospitals of Haikou from 2007 to 2009

作　　者：符锐[1] 陈萍[1] 

机构地区：[1]海南省人民医院药学部,海口市570311

出　　处：《中国药房》2010年第30期2802-2804,共3页China Pharmacy

摘　　要：目的:评价海口地区医院降血脂药的应用情况及趋势。方法:对海口地区2家医院2007～2009年降血脂药的销售金额、用药频度、日均费用等进行回顾性统计、分析。结果:该地区2家医院降血脂药的销售金额逐年上升,2008年比2007年增长41.25%,2009年比2008年增长28.96%,主要药品是阿托伐他汀、普伐他汀、氟伐他汀、辛伐他汀、苯扎贝特;销售金额排序与用药频度排序列第1位的每年都是阿托伐他汀。结论:他汀类降血脂药在海口地区降血脂药市场中居于首位,其市场前景看好。OBJECTIVE：To evaluate the utilization of blood lipid-lowering drugs in Haikou area.METHODS：The consumption sum,DDDs and DDC of blood lipid-lowering drugs in 2 hospitals of Haikou area from 2007 to 2009 were analyzed retrospectively.RESULTS：The consumption sum of blood lipid-lowering drugs in Haikou area increased year by year,up by 41.25% in 2008 than in 2007 and 28.96% in 2009 than in 2008.Blood lipid-lowering drugs were mainly atorvastatin,pravastatin,fluvastatin,simvastatin,bezafibrate.Atorvastatin took up the first place of the list of consumption sum and DDDs in past 3 years.CONCLUSION：Statins occupy the predominate place among blood lipid-lowering drugs and show potential in the market.

关 键 词：降血脂药 用药频度 日均费用 用药分析 

分 类 号：R969.3[医药卫生—药理学] R287[医药卫生—药学]